Loading...
OTCMNOUV
Market cap90kUSD
Dec 23, Last price  
0.00USD
1D
0.00%
1Q
0.00%
Jan 2017
-66.67%
Name

Nouveau Life Pharmaceuticals Inc

Chart & Performance

D1W1MN
OTCM:NOUV chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
Net income
0k
-253,995-312,249-401,431-256,816-357,2480000
CFO
0k
-11,372-81,148-64,296-84,947-22,9070000

Profile

Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012. Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.
URL
IPO date
Jun 21, 2001
Employees
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
0.00
-83.33%
0.00
1,400.00%
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT